Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma. Neoadjuvant nivolumab, paclitaxel ...
This trial looked at adding nimorazole to radiotherapy to improve treatment for certain types of head and neck cancer. It was for people with cancer that may have spread into surrounding tissues but ...